The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 6th 2024
The rheumatology month in review emphasizes new trends in medication use and novel technologies' potential for managing fibromyalgia.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Addex Drug for Osteoarthritis Pain to Begin Clinical Trials
July 13th 2010A drug being tested for osteoarthritis pain has proven effective in a model of OA pain. Manufactured by Addex Pharmaceuticals Ltd., ADX71943 modulates gamma-aminobutyric acid subtype B (GABA-B) receptors. These receptors are implicated in pain processing.
Recommendations for Active Patients with OA of the Knee
July 8th 2010Surgical and non-surgical interventions are allowing young men and women with osteoarthritis of the knee to return to demanding sports and remain active, according to a review published in the Journal of the American Academy of Orthopaedic Surgeons.
Managing pediatric musculoskeletal infections:The significant organisms
July 5th 2010Septic arthritis and several other types of musculoskeletal infections in children are caused by group A Streptococcus. Methicillin-resistant Staphylococcus aureus is emerging as a cause of skin infections in the sports community. Neisseria meningitidis in purpura fulminans usually is not associated with direct infection of musculoskeletal structures.
Inflammatory bone loss in joint replacements: The key mediators
July 4th 2010The immune system plays a dynamic role in physiological and pathogenic bone remodeling. Macrophage-, stromal-, and lymphocyte-derived cytokines may induce the activation or inhibition of bone cells and their precursors and cause bone deposition or bone resorption.
Gout pain “excruciating” but not always taken seriously
July 3rd 2010More than two-thirds of surveyed patients with gout described the pain of an attack as “miserable,” but one-fourth suggested that persons who do not have gout perceive them as overreacting to attacks and two-thirds think that others do not take the condition seriously.
EULAR 2010 report: RA pain in women and other arthritis findings
July 2nd 2010Close to three-fourths of women who have rheumatoid arthritis (RA) experience pain on a daily basis, even though three-fourths receive medication for pain relief, according to a new study presented at the 2010 Annual Congress of the European League Against Rheumatism (EULAR), held recently in Rome.
Survey: Fewer older persons have osteoporosis
July 1st 2010The number of older persons in the United States who have osteoporosis is declining, according to findings from the National Institute of Arthritis and Musculoskeletal and Skin Diseases–supported National Health and Nutrition Examination Survey (NHANES).
Achilles tendon rupture treatment guidelines: Exercise caution
June 30th 2010Operative treatment for patients with an Achilles tendon rupture should be approached more cautiously in persons older than 65 years and in other patient groups, according to a consensus recommendation in an evidence-based clinical practice guideline, The Diagnosis and Treatment of Acute Achilles Tendon Rupture, recently released by the American Academy of Orthopaedic Surgeons (AAOS)
Osteoarthritis Summit Set For June 2011
June 30th 2010For the first time, Hospital for Special Surgery will host an international Osteoarthritis Summit in June 2011 that will bring together a comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the US, Canada, and Europe.
Vitamin D results in more-not fewer-falls and fractures in older women
June 28th 2010lder community-dwelling women who receive annual high-dose cholecalciferol (vitamin D) experience more falls and fractures-and more fractures unrelated to falls-than those who do not. This unexpected adverse outcome may be dose-related.
Current treatments are good medicine for children with Lyme arthritis
June 28th 2010Children with Lyme arthritis have an excellent prognosis. Treatment of patients who have antibiotic-refractory Lyme arthritis with NSAIDs, intra-articular corticosteroid injections, or disease-modifying antirheumatic drugs (DMARDs) is safe and effective, with no evidence of chronic arthritis, permanent joint changes, or breakthrough cases of persistent infection.
Challenging the intervertebral disk degeneration paradigm
June 28th 2010Traditionally recognized factors, such as age and biomechanics (abnormal physical loading), may play a role in the manifestation of intervertebral disk degeneration, according to researchers in the department of orthopaedics & traumatology at the University of Hong Kong. However, additional factors also may contribute.